论文部分内容阅读
目的探讨管状胃与全胃重建食管治疗食管癌的疗效。方法 167例食管癌根治术患者,其中管状胃代食管85例(A组),全胃重建食管82例(B组),对两组患者术后生存质量及生存时间进行回顾性分析。结果 A组围手术期胃肠减压管引流量、返流性食管炎、肺部并发症明显少于B组(P<0.05)。A组术后1年生存质量优于B组(P<0.05)。结论管状胃代食管治疗食管癌疗效优于全胃代食管。
Objective To investigate the curative effect of tubular stomach and total stomach reconstruction esophagus on esophageal cancer. Methods A total of 167 patients undergoing radical resection of esophageal cancer, including 85 cases of tubular gastric esophageal esophagus (group A) and 82 cases of esophageal reconstruction (group B), were retrospectively analyzed for their postoperative quality of life and survival time. Results A group of perioperative gastrointestinal decompression tube drainage, reflux esophagitis, lung complications were significantly less than the B group (P <0.05). The quality of life at 1 year after operation in group A was better than that in group B (P <0.05). Conclusion Tubular gastric esophageal esophageal cancer treatment is better than the whole stomach on behalf of the esophagus.